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Introduction
HTLV-1 is an endemic virus in the northeast of Brazil
and is related to HAM/TSP in up to 5% of infected indi-
viduals. Despite this low prevalence it is known that a
higher number of carriers presents with clinical and neu-
rological symptoms that can be sensory, motor, urinary,
inflammatory or autonomic.
Method
This is a cohort study with 440 HTLV-1 infected indivi-
duals in Salvador, Bahia. Symptoms were computed every
year and incidence rates were calculated to each variable
in data.
Results
Applying international criteria 163 individuals had defi-
nite, possible or probable HAM/TSP and 266 were
asymptomatic. The last was selected for analysis. Follow-
up of at least one year was archived in 64 to 75% of
patients, varying according to the studied variable. The
symptoms incidence rate was 20.6% for hand numbness,
18.6% for feet numbness, 12.9% for nocturia, 12.6% for
urgency and 13.3% for dry mouth. In the physical exam
the incidence was 22.7% for gingivitis, 7.6% for legs
hyperreflexia, 5.2% for legs paraparesis and 3.6% for
Babinski sign. In annual applied EDSS scale the incidence
rate of worsening 1 point was 13.4%. Cox regression was
done with EDSS curves and identified proviral load and
female gender as significant risk factors (ORs 3.36
[1-11.66] and 1.80 [1.09-2.97] respectively). Six patients
developed HAM/TSP during the cohort.
Conclusion
Developing of neurological symptoms or signs occurred
in up to 30% of asymptomatic patients during 8 years
follow-up. The estimated incidence was 12% for overac-
tive bladder syndrome and 2.25% for definite HAM/TSP.
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